Ad copy

Most women with actinic keratosis are treating the wrong layer. That's not an opinion. It's biology. And it's the reason your patches keep coming back every quarter despite perfect compliance, despite every freeze session, despite the diclofenac you apply every single morning without fail. I'm going to explain exactly what's happening beneath your skin. Not the surface story your dermatologist tells you. The actual biology. Because once you understand it, you'll never look at a freeze session the same way again. --- Your skin has seven layers. The outermost layer — the stratum corneum — is a lipid barrier. Oil-based by design. It keeps water out and moisture in. It's one of the most sophisticated barriers in the human body. It also blocks every water-based compound you've ever been prescribed for actinic keratosis. Diclofenac gel: water-based. Hits the stratum corneum and sits on the surface. Less than 4% reaches the dermis. Vitamin C serums: water-based. Same barrier. Same outcome. 5-fluorouracil field therapy: water-based. It forces surface cell turnover. The dermis underneath stays untouched. Every compound your dermatologist has prescribed for your actinic keratosis field was water-based. And the field lives in the dermis. Behind a lipid barrier that water-based compounds physically cannot cross. That's not a treatment failure. That's a delivery failure. And delivery failures can be fixed. --- Now here's what's happening in the dermis while the surface is being treated. Deep in your skin — below the stratum corneum, below the epidermis, in the dermis itself — UV radiation has created a subclinical field of damaged keratinocytes. These cells are misfiring. Dividing in 3 to 5 days instead of the normal 28 to 30 day cycle. They spread invisibly through the surrounding dermis. Recruiting neighboring cells. Expanding the field outward week by week. Month by month. Season by season. The visible patch on your forearm is the endpoint of this process — the moment the abnormally dividing keratinocytes pile up enough to break through the surface and become visible. Your dermatologist freezes that patch. The visible endpoint is destroyed. Clean. Gone. But the subclinical field generating the next endpoint is still there. Still misfiring. Still dividing. Still spreading. Three months later: a new patch appears in skin that looked completely clear at your last visit. Your dermatologist freezes that one too. Three months later: another one. This is not a treatment. This is patch management. And it will continue indefinitely because the source is never addressed. --- Here's what the left side of this image represents: Normal keratinocytes. Healthy dermis. Normal 28 to 30 day cell cycling. Smooth, even skin at the surface. No abnormal proliferation signal. No subclinical field. This is what your skin looked like before decades of UV exposure locked the proliferation signal into the permanent ON position. Here's what the right side represents: Abnormal keratinocytes misfiring in the dermis. UV-induced oxidative cascade locked ON. Subclinical field spreading invisibly in the surrounding tissue. Visible patches emerging at the surface as the endpoint of a process that started weeks or months earlier. And here's what neither side shows: The water-based compounds sitting on the stratum corneum surface. Never reaching the dermis. Never touching the field. While the quarterly freeze schedule clears each visible endpoint and waits for the next one to emerge. That's the biology of why nothing has worked. --- What reaches the dermis when water-based compounds can't? Lipid-based carriers. Specifically cold-pressed plant oils — camellia oil and sea buckthorn oil — with the molecular structure to penetrate all seven skin layers and deliver oil-soluble actives to the dermis. Right to where the subclinical field lives. Oil dissolves oil. The stratum corneum is a lipid barrier. A lipid-based carrier crosses it. A water-based compound cannot. When oil-soluble vitamin C — ascorbyl tetraisopalmitate, not ascorbic acid — is carried through the stratum corneum by cold-pressed camellia and sea buckthorn oil, it reaches the dermis. Where it directly neutralizes the UV-induced oxidative cascade driving abnormal keratinocyte proliferation. Not on the surface. In the dermis. Where the field actually lives. When bakuchiol at clinical concentration is delivered the same way, it reaches the dermis and supports normal keratinocyte cycling — replacing the abnormal 3 to 5 day proliferation pattern with healthy 28 to 30 day cell renewal from the inside out. Zero water in the formula. Because every drop of water dilutes penetration. Everything oil-soluble. Everything lipid-delivered. Everything reaching the field. This is the biology the quarterly freeze schedule was never designed to address. --- Let me tell you what happens when you actually reach the field. A 67-year-old patient. Nine years on the quarterly freeze schedule. Both forearms. Both hands. Upper arms. Chest. Seventeen active sites. Her previous dermatologist had recommended photodynamic therapy — three sessions at $800 each — followed by 5-fluorouracil field chemotherapy twice daily for six weeks. She came to me for a second opinion. "Nine years," she said. "Thirty-six freeze sessions. And it keeps spreading." I explained the biology. The subclinical field in the dermis. The water-based delivery failure. Less than 4% of her diclofenac ever reaching the layer where the field lived. The freeze sessions destroying each visible endpoint while the field generated the next one. She looked at me for a long time. "Why has nobody ever explained this to me before?" I recommended 12 weeks of lipid-delivered botanical field support before making any photodynamic therapy decisions. Week 2: rough sandpaper texture softening on her worst forearm. Week 4: raised edges flattening. Week 8: no new lesions at eight sites that had been actively generating every quarter for years. Week 12: Active lesion count: seventeen sites down to four. New lesion generation: zero at thirteen previously active sites. She cancelled the photodynamic therapy. She cancelled the field chemotherapy. "Nine years," she said at her twelve-week appointment. "Nobody ever reached the field before." --- The product I recommend is Dermiqua. Cold-pressed camellia and sea buckthorn oil as the lipid carrier — the two oils that actually penetrate all seven skin layers to the dermis. Not sunflower. Not jojoba. Those sit on the surface. These go through it. Oil-soluble vitamin C — ascorbyl tetraisopalmitate — at clinical concentration. Carried through the stratum corneum to the dermis. Directly neutralizing the UV-induced oxidative cascade driving the abnormal proliferation. Not on the surface. In the dermis. Where the field lives. Bakuchiol at clinical concentration for natural cellular turnover. Supporting normal keratinocyte cycling from the dermis out. Without the rebound irritation retinol causes in UV-damaged skin. Sixteen cold-pressed botanicals. Zero water. Zero filler. Applied morning and evening — because the field doesn't rest. 90-day money-back guarantee. If the rough texture isn't smoothing, if the raised edges aren't flattening, if new lesions are still appearing on the same quarterly schedule — every penny back. I have no financial relationship with this company. I recommend it because the mechanism matches the biology, the research supports it, and I've seen it work. Your patches aren't coming back because of poor compliance. They're coming back because the water-based compounds you've been prescribed were never physically capable of crossing the stratum corneum to reach the field generating them. The right side of this image shows what happens in the dermis when the subclinical field runs unchecked. Dermiqua reaches the left side. The normal. The field before it locked into abnormal proliferation. The keratinocytes before they started misfiring. That's the biology of what's possible when you actually reach the field. 👉 dermiqua.com/pages/actinic-keratosis — Dr. Elena Brandt, MD Dermatologist, formerly of University of Zurich Medical Center Currently practicing in Boston, MA P.S. — The field is generating right now. Every week without deep-dermis support is another week it recruits surrounding tissue. Every quarter you wait is another set of new patches in skin that looks clear today. The biology doesn't wait for the quarterly appointment schedule. P.P.S. — Nine years. Thirty-six freeze sessions. Seventeen active sites. Twelve weeks of morning and evening oil. Thirteen sites with zero new lesion generation. The field was reachable the whole time. The delivery system just wasn't right. P.P.P.S. — Your dermatologist is treating the right side of this image with tools designed for the surface. Dermiqua reaches the dermis where the field actually lives. Add it to your morning and evening routine. The freeze sessions clear what's visible. This addresses what's generating.